Wound Care Products
ABI supply is a premier medical supplier of the most advanced, scientifically proven, products used for healing wounds and controlling infections. Products supplied by ABI are FDA-compliant and meet the highest standards of safety. Some products require the use of a Doctor, Physician Assistant, Podiatrist, Doctor of Osteopathic Medicine/Optometry, or Nurse Practitioner. If you have a qualified provider they can contact us or feel free to call, ABI has a network of experienced chronic wound care cliniciansm trained to treat chronic wounds.INFECTION CONTROL:
Antimicrobial Wound Gel
Antimicrobial Wound Gel
Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing. While in place, the antimicrobial properties of the gel inhibit the growth of microorganisms in the product.Product Features
– Provides a moist wound environment, conducive to healing
– Biocompatible
– Prevents bacterial growth within the gel
– Broad spectrum efficacy
Sterile Antimicrobial Wound Gel
Sterile Antimicrobial Gel conforms to the postoperative wound. The gel provides a moist wound environment conducive to healing. While in place, the antimicrobial properties of the gel inhibit the growth of microorganisms in the product.Product Features
– Provides a moist wound environment, conducive to healing
– Biocompatible
– Prevents bacterial growth within the gel
– Broad spectrum efficacy
No Rinse Wound Cleaning
No Rinse Cleaning & Debris Solution
Designed to clean wounds and remove debris, including microorganisms from wounds.
Product Features
– 5+ hours of ongoing protection within the solution
– No secondary rinse out required
– Broad spectrum efficacy
– Compatible with most pulsed lavage systems
Amniotic Membrane Grafts & Injections
Wound healing usually follows a predictable sequence and prognosis of events. Its evolutionary process is the result of a complicated interaction between patient-related factors, the wound, the treatment used, and the skills and knowledge of the professionals who treat them. Only through a meticulous initial assessment of the wound is it possible to identify the factors that contribute to its complexity. The challenge for professionals will be to implement efficient therapies at the right time and in the most cost-efficient way in order to reduce associated problems, treat the symptoms and expectations of the patients, and achieve adequate wound healing whenever possible. This is particularly evident in big chronic wounds with considerable tissue loss, which become senescent in the process of inflammation or proliferation losing the ability to epithelialize.
Generally, chronic wounds do not respond to current treatments, therefore they need special interventions. AM is a tissue of particular interest as a biological dressing and it has well-documented reepithelialization effects which are in part related to its capacity to synthesize and release biological active factors. Our studies have demonstrated that the amniotic membrane (AM) is able to induce epithelialization in chronic wounds that were unable to epithelialize. AM induces several signaling pathways that are involved in cell migration and/or proliferation. Additionally, AM is able to selectively antagonize the antiproliferative effect of transforming growth factor-ß (TGF-β) by modifying the genetic program that TGF-β induces in keratinocytes. The combined effect of AM on keratinocytes, promoting cell proliferation/migration and antagonizing the effect of TGF-β is the perfect combination, allowing chronic wounds to move out of their non-healing state and progress into epithelialization.
